You are here: Industry Insights > 2023

News List

Global top 20 Best-Selling Race of Medicine by 2023 Shruti Talashi
September 26, 2024
Top 20 medications by global sales list of 2023 was not without its surprises, given the year's significant patent expirations, the emergence of weight-loss medications, and other novel developments.
Inventory of New Drug Targets in 2023 roger
May 21, 2024
In 2023, 49 new drugs received their first approval in the United States, the European Union, and Japan.
On the Path to Net Zero: Vetter Achieves New Sustainability Goals in 2023 PharmaSources
May 09, 2024
Alongside its dynamic growth, Vetter announced that it achieved its sustainability goals for 2023.
InnoCare Releases 2023 Results and Business Highlights PharmaSources
March 29, 2024
InnoCare Pharma, a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced the 2023 annual results as of 31 December 2023.
An Overview to 2023 Pharmaceutical Industry by PharmaSources Experts PharmaSources
March 07, 2024
20 Selected Articles by PharmaSources Experts in 2023
Block-buster Small Molecule Pharmaceuticals Approved by the NMPA in 2023 Yefenghong
March 06, 2024
According to data collated from the National Medical Products Administration (NMPA) official website, a total of more than 80 new drugs were granted inaugural approval within the domestic market.
Vetter Contributes to Commercial Launches of Eight Customer Products in 2023 PharmaSources
February 18, 2024
February 14, 2024 Vetterannounces the successful commercialization of eight customer drug products as of the completion of 2023.
Advancements in scientific technologies to Drug discovery and Development 2023 Shruti Talashi
January 02, 2024
Technological advancement apart from a deeper comprehension of disease biology, and an emphasis on breaking down conventional boundaries is driving this era of profound change in the drug development industry.
Global R&D Drug Development 2023: Overcoming Barriers, Bringing Hope to Patients and ESG focused Shruti Talashi
January 02, 2024
As the global healthcare system refocuses after the pandemic, a recent report on the global R&D trend 2023 which was put together as a public service by the IQVIA Institute for Human Data Science.
New regulations in the Year 2023 for different regulatory bodies around the world Muhammad Asim Niazi
January 23, 2024
This article will explore new regulations in countries like the United States, Europe, Japan, and Australia.